{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T06:52:47Z","timestamp":1774853567718,"version":"3.50.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Based on accumulating evidence, this article proposes redefining Kawasaki disease as a chronic condition that begins with an acute immune response and leads to lasting vascular and immune dysfunction. This perspective moves beyond the traditional view of Kawasaki disease as a \u201cself-limited vasculitis,\u201d emphasizing that its pathological processes continue long after acute symptoms resolve. The disease follows a continuum involving persistent immune activation, ongoing low-grade inflammation, impaired blood vessel function, and metabolic changes. This chronic disease model explains why patients face accelerated atherosclerosis and higher long-term cardiovascular risk. The article systematically reviews the biology of the disease from its acute to chronic stages, summarizes supporting clinical and imaging evidence, and discusses the implications for lifelong patient management, personalized treatment strategies, and future research across multiple disciplines.<\/jats:p>","DOI":"10.3389\/fped.2026.1764216","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:26:07Z","timestamp":1774848367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From acute immune storm to lifelong vascular risk: a paradigm shift in Kawasaki disease as a chronic disease model"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiong-xiong","family":"Yi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yan\u2019an People\u2019s Hospital","place":["Yan\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-rong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yan\u2019an People\u2019s Hospital","place":["Yan\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-mei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yan\u2019an People\u2019s Hospital","place":["Yan\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yan\u2019an People\u2019s Hospital","place":["Yan\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-xia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Yan\u2019an People\u2019s Hospital","place":["Yan\u2019an, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1017\/S1047951122002906","article-title":"Long-term vascular dysfunction in kawasaki disease: systematic review and meta-analyses","volume":"33","author":"Patra","year":"2023","journal-title":"Cardiol Young"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.3390\/diagnostics13132151","article-title":"Kawasaki disease and inborn errors of immunity: exploring the link and implications","volume":"13","author":"Sharma","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1542\/peds.2013-1638","article-title":"Long-term cardiovascular outcomes in survivors of kawasaki disease","volume":"133","author":"Holve","year":"2014","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12887-025-05724-3","article-title":"Long-term risk of allergic disorders following kawasaki disease: a population-based cohort study","volume":"25","author":"Seol","year":"2025","journal-title":"BMC Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.18176\/jiaci.0300","article-title":"Autoimmune aspects of kawasaki disease","volume":"29","author":"Sakurai","year":"2019","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.3390\/ijms252413322","article-title":"Endothelial dysfunction: molecular mechanisms and therapeutic strategies in Kawasaki disease","volume":"25","author":"Paolini","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3345\/kjp.2014.57.11.472","article-title":"Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis","volume":"57","author":"Cheung","year":"2014","journal-title":"Korean J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2406282","DOI":"10.1002\/advs.202406282","article-title":"Platelet-monocyte aggregate instigates inflammation and vasculopathy in Kawasaki disease","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","article-title":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-\u03b3 as biomarkers for early recognition","volume":"17","author":"Li","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1438640","DOI":"10.3389\/fimmu.2024.1438640","article-title":"The mechanism underlying B-cell developmental dysfunction in Kawasaki disease based on single-cell transcriptomic sequencing","volume":"15","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1640024","DOI":"10.3389\/fimmu.2025.1640024","article-title":"Polymorphism-driven immune disruptions in Kawasaki disease across populations: decoding the role of T and B-cells","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1566985","DOI":"10.3389\/fimmu.2025.1566985","article-title":"Pyroptosis in Kawasaki disease: from mechanisms to targeted interventions","volume":"16","author":"Han","year":"2025","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"166707","DOI":"10.1016\/j.bbadis.2023.166707","article-title":"Single cell RNA-Seq resolution revealed CCR1+\/SELL+\/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19","volume":"1869","author":"Liu","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/JIR.S293993","article-title":"Altered monocyte subsets in Kawasaki disease revealed by single-cell RNA-Sequencing","volume":"14","author":"Geng","year":"2021","journal-title":"J Inflamm Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1557231","DOI":"10.3389\/fimmu.2025.1557231","article-title":"CD14+ monocytes: the immune communication hub in early vasculitis symptoms of Kawasaki disease","volume":"16","author":"Song","year":"2025","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12016-024-08985-5","article-title":"Markers of endothelial dysfunction in Kawasaki disease: an update","volume":"66","author":"Kumrah","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12519-021-00452-x","article-title":"Are patients recovering from Kawasaki disease at increased risk for accelerated atherosclerosis? A meta-analysis","volume":"17","author":"Zeng","year":"2021","journal-title":"World J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"671198","DOI":"10.3389\/fcvm.2021.671198","article-title":"An update on cardiovascular risk factors after Kawasaki disease","volume":"8","author":"Zeng","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e040687","DOI":"10.1161\/JAHA.124.040687","article-title":"Interleukin-1 signaling on vascular smooth muscle cells accelerates atherosclerosis in a murine model of Kawasaki disease","volume":"14","author":"Chen","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/HCO.0b013e3283588f06","article-title":"Kawasaki disease: late cardiovascular sequelae","volume":"27","author":"Daniels","year":"2012","journal-title":"Curr Opin Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3345\/kjp.2014.57.5.217","article-title":"Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease","volume":"57","author":"Cho","year":"2014","journal-title":"Korean J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.6515\/acs20150424e","article-title":"High sensitivity C reactive protein (hs-CRP) in adolescent and young adult patients with history of Kawasaki disease","volume":"31","author":"Chen","year":"2015","journal-title":"Acta Cardiol Sin"},{"key":"B24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5409\/wjcp.v11.i4.360","article-title":"Adipocytokine profile in children with Kawasaki disease at a mean follow-up period of 5.5 years: a study from North India","volume":"11","author":"Praharaj","year":"2022","journal-title":"World J Clin Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3760\/cma.j.issn.0578-1310.2005.08.116","article-title":"Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions","volume":"43","author":"Yang","year":"2005","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.amjcard.2014.09.004","article-title":"Coronary computed tomographic angiographic findings in patients with Kawasaki disease","volume":"114","author":"Han","year":"2014","journal-title":"Am J Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00296-013-2820-2","article-title":"Carotid intima-media thickness in children with Kawasaki disease","volume":"34","author":"Meena","year":"2014","journal-title":"Rheumatol Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/adc.2006.096628","article-title":"Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease","volume":"92","author":"Cheung","year":"2007","journal-title":"Arch Dis Child"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/rheumatology\/keab680","article-title":"Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study","volume":"61","author":"Fung","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/ijr.15.33","article-title":"Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions","volume":"10","author":"Hong","year":"2015","journal-title":"Int J Clin Rheumtol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1543767","DOI":"10.3389\/fcvm.2025.1543767","article-title":"A risk stratification model for coronary artery lesions in Kawasaki disease: focus on subgroup-specific utility","volume":"12","author":"Gong","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/cdt.2017.06.09","article-title":"Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery","volume":"8","author":"Noto","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1440-1754.2005.00555.x","article-title":"The diagnosis and management of Kawasaki disease","volume":"41","author":"Royle","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jacc.2013.04.090","article-title":"Vascular health in Kawasaki disease","volume":"62","author":"Selamet Tierney","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0130913","DOI":"10.1371\/journal.pone.0130913","article-title":"Peripheral endothelial (dys)Function, arterial stiffness and carotid intima-Media thickness in patients after Kawasaki disease: a systematic review and meta-analyses","volume":"10","author":"Dietz","year":"2015","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/heartjnl-2019-315925","article-title":"Lifetime cardiovascular management of patients with previous Kawasaki disease","volume":"106","author":"Brogan","year":"2020","journal-title":"Heart"},{"key":"B38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/AMEP.S399178","article-title":"Teaching medical students about Kawasaki disease: the development and evaluation of a digital educational resource","volume":"14","author":"Song","year":"2023","journal-title":"Adv Med Educ Pract"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13001","DOI":"10.1002\/jcb.28571","article-title":"Comprehensive analyses of DNA methylation and gene expression profiles of Kawasaki disease","volume":"120","author":"Chang","year":"2019","journal-title":"J Cell Biochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","article-title":"Kawasaki disease: pathophysiology and insights from mouse models","volume":"16","author":"Noval Rivas","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"738850","DOI":"10.3389\/fmed.2021.738850","article-title":"Anti-inflammatory treatment of Kawasaki disease: comparison of current guidelines and perspectives","volume":"8","author":"Buda","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e011319","DOI":"10.1161\/JAHA.118.011319","article-title":"Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population","volume":"8","author":"Son","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0154943","DOI":"10.1371\/journal.pone.0154943","article-title":"Genome-wide association study identifies novel susceptibility genes associated with coronary artery aneurysm formation in Kawasaki disease","volume":"11","author":"Kuo","year":"2016","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/pch\/pxab092","article-title":"Health care utilization and costs following Kawasaki disease","volume":"27","author":"Robinson","year":"2022","journal-title":"Paediatr Child Health"},{"key":"B45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jjcc.2022.03.005","article-title":"Cost-effectiveness analysis of infliximab for the treatment of Kawasaki disease refractory to the initial treatment: a retrospective cohort study","volume":"80","author":"Takura","year":"2022","journal-title":"J Cardiol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1764216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:26:09Z","timestamp":1774848369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1764216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":45,"alternative-id":["10.3389\/fped.2026.1764216"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1764216","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1764216"}}